Update on Usher syndrome

Current Opinion in Neurology

Volumn 22, Issue 1, 2009, Pages 19-27

  Saihan, Zubin ^a   Webster, Andrew R ^a   Luxon, Linda ^b   Bitner Glindzicz, Maria ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Inner ear; Retina; Usher syndrome

Indexed keywords

CADHERIN 23; CLARIN 1; HARMONIN PROTEIN; MASS1 PROTEIN; MYOSIN VIIA; PROTEIN; PROTOCADHERIN 15; SCAFFOLD PROTEIN CONTAINING ANKYRIN REPEAT AND SAM DOMAIN; UNCLASSIFIED DRUG; USHERIN; WHIRLIN;

AREFLEXIA; BLINDNESS; CLINICAL FEATURE; DISEASE COURSE; EXPERIMENTAL MODEL; GENE LOCUS; GENE MUTATION; GENETIC HETEROGENEITY; HAIR CELL; HEARING LOSS; HUMAN; INNER EAR; NONHUMAN; PATHOGENESIS; PROGNOSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RETINITIS PIGMENTOSA; REVIEW; SYNAPSE; USHER SYNDROME;

ALLELES; ANIMALS; DATABASES, GENETIC; DISEASE MODELS, ANIMAL; EAR, INNER; EXTRACELLULAR MATRIX PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HAIR CELLS, AUDITORY; HUMANS; MUTATION; MYOSINS; PHENOTYPE; PROTEIN ISOFORMS; RETINA; USHER SYNDROMES;

EID: 60549091982     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283218807     Document Type: Review

References (117)

1. Nikolopoulos TP, Lioumi D, Stamataki S, O'Donoghue GM. Evidence-based overview of ophthalmic disorders in deaf children: a literature update. Otol Neurotol 2006; 27 (2 Suppl 1):S1 -S24; discussion SO.
2. Marazita ML, Ploughman LM, Rawlings B, et al. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet 1993; 46:486-491.
3. Rosenberg T, Haim M, Hauch AM, Parving A. The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations. Clin Genet 1997; 51:314-321.
4. Spandau UH, Rohrschneider K. Prevalence and geographical distribution of Usher syndrome in Germany. Graefes Arch Clin Exp Ophthalmol 2002; 240:495-498.
5. Boughman JA, Vernon M, Shaver KA. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis 1983; 36:595-603.
6. Grondahl J. Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway. Clin Genet 1987; 31:255-264.
7. Davenport SLH, Omenn GS. The heterogeneity of Usher syndrome. Vth International Conference Birth Defects; 1977. 1977.
8. Petit C. Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet 2001; 2:271-297.
9. Eudy JD, Weston MD, Yao S, et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type lla. Science 1998; 280:1753-1757.
10. Joensuu T, Hamalainen R, Lehesjoki AE, et al. A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q. Genomics 2000; 63:409-416.
11. Karjalainen S, Pakarinen L, Terasvirta M, et al. Progressive hearing loss in Usher's syndrome. Ann Otol Rhinol Laryngol 1989; 98:863-866.
12. Pakarinen L, Karjalainen S, Simola KO, et al. Usher's syndrome type 3 in Finland. Laryngoscope 1995; 105:613-617.
13. Adato A, Vreugde S, Joensuu T, et al. USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory sy-napses. Eur J Hum Genet 2002; 10:339-350.
14. Fields RR, Zhou G, Huang D, et al. Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations. Am J Hum Genet 2002; 71:607-617.
15. Ness SL, Ben-Yosef T, Bar-Lev A, et al. Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III. J Med Genet 2003; 40:767-772.
16. Hope CI, Bundey S, Proops D, Fielder AR. Usher syndrome in the city of Birmingham-prevalence and clinical classification. Br J Ophthalmol 1997; 81:46-53.
17. Tsilou ET, Rubin BI, Caruso RC, et al. Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types? Acta Ophthalmol Scand 2002; 80:196-201.
18. Cohen M, Bitner-Glindzicz M, Luxon L. The changing face of Usher syndrome: clinical implications. Int J Audiol 2007; 46:82-93.
19. Kumar A, Fishman G, Torok N. Vestibular and auditory function in Usher's syndrome. Ann Otol Rhinol Laryngol 1984; 93 (6 Pt 1):600-608.
20. Moller CG, Kimberling WJ, Davenport SL, et al. Usher syndrome: an otoneurologic study. Laryngoscope 1989; 99:73-79.
21. Iannaccone A, Kritchevsky SB, Ciccarelli ML, et al. Kinetics of visual field loss in Usher syndrome Type II. Invest Ophthalmol Vis Sci 2004; 45:784-792.
22. Kimberling WJ, Moller CG, Davenport S, et al. Linkage of Usher syndrome type I gene (USH1 B) to the long arm of chromosome 11. Genomics 1992; 14:988-994.
23. Weil D, Kussel P, Blanchard S, et al. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat Genet 1997; 16:191-193.
24. Verpy E, Leibovici M, Zwaenepoel I, et al. A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat Genet 2000; 26:51-55.
25. Bitner-Glindzicz M, Lindley KJ, Rutland P, et al. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet 2000; 26:56-60.
26. Bork JM, Peters LM, Riazuddin S, et al. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet 2001; 68:26-37.
27. Bolz H, von Brederlow B, Ramirez A, et al. Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat Genet 2001; 27:108-112.
28. Chaib H, Kaplan J, Gerber S, et al. A newly identified locus for Usher syndrome type I, USH1E, maps to chromosome 21q21. Hum Mol Genet 1997; 6:27-31.
29. Alagramam KN, Yuan H, Kuehn MH, et al. Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet 2001; 10:1709-1718.
30. Ahmed ZM, Riazuddin S, Bernstein SL, et al. Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am J Hum Genet 2001; 69:25-34.
31. Weil D, EI-Amraoui A, Masmoudi S, et al. Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. Hum Mol Genet 2003; 12:463-471.
32. van Wijk E, Pennings RJ, te Brinke H, et al. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. Am J Hum Genet 2004; 74:738-744.
33. Hmani M, Ghorbel A, Boulila-Elgaied A, et al. A novel locus for Usher syndrome type II, USH2B, maps to chromosome 3 at p23-24.2. Eur J Hum Genet 1999; 7:363-367.
34. Weston MD, Luijendijk MW, Humphrey KD, et al. Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II. Am J Hum Genet 2004; 74:357-366.
35. Ebermann I, Scholl HP, Charbel Issa P, et al. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. Hum Genet 2007; 121:203-211.
36. Ahmed ZM, Smith TN, Riazuddin S, et al. Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC. Hum Genet 2002; 110:527-531.
37. Liu XZ, Walsh J, Mburu P, et al. Mutations in the myosin VIIA gene cause nonsyndromic recessive deafness. Nat Genet 1997; 16:188-190.
38. Mburu P, Mustapha M, Varela A, et al. Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31. Nat Genet 2003; 34:421-428.
39. Rivolta C, Sweklo EA, Berson EL, Dryja TP. Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. Am J Hum Genet 2000; 66:1975-1978.
40. Seyedahmadi BJ, Rivolta C, Keene JA, et al. Comprehensive screening of the USH2A gene in Usher syndrome type II and nonsyndromic recessive retinitis pigmentosa. Exp Eye Res 2004; 79:167-173.
41. Astuto LM, Bork JM, Weston MD, et al. CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 2002; 71:262-275.
42. Ben-Yosef T, Ness SL, Madeo AC, et al. A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome. N Engl J Med 2003; 348:1664-1670.
43. Gerber S, Bonneau D, Gilbert B, et al. USH1 A: chronicle of a slow death. Am J Hum Genet 2006; 78:357-359.
44. Kremer H, van Wijk E, Marker T, et al. Usher syndrome: molecular links of pathogenesis, proteins and pathways. Hum Mol Genet 2006; 15 Spec No 2:R262-70.
45. Ahmed ZM, Riazuddin S, Ahmad J, et al. PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleies are responsible for both USH1 F and DFNB23. Hum Mol Genet 2003; 12:3215-3223.
46. Ouyang XM, Xia XJ, Verpy E, et al. Mutations in the alternatively spliced exons of USH1C cause nonsyndromic recessive deafness. Hum Genet 2002; 111:26-30.
47. Bork JM, Morell RJ, Khan S, et al. Clinical presentation of DFNB12 and Usher syndrome type 1D. Adv Otorhinolaryngol 2002; 61:145-152.
48. Le Guedard S, Faugere V, Malcolm S, et al. Large genomic rearrangements within the PCDH15 gene are a significant cause of USH1 F syndrome. Mol Vis 2007; 13:102-107.
49. Liu XZ, Blanton SH, Bitner-Glindzicz M, et al. Haplotype analysis of the USH1D locus and genotype-phenotype correlations. Clin Genet 2001; 60:58-62.
50. Roux AF, Faugere V, Le Guedard S, et al. Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%. J Med Genet 2006; 43:763-768.
51. Liu XZ, Hope C, Liang CY, et al. A mutation (2314delG) in the Usher syndrome type NA gene: high prevalence and phenotypic variation. Am J Hum Genet 1999; 64:1221-1225.
52. Bernai S, Meda C, Solans T, et al. Clinical and genetic studies in Spanish patients with Usher syndrome type II: description of new mutations and evidence for a lack of genotype-phenotype correlation. Clin Genet 2005; 68:204-214.
53. van WijkE, van der Zwaag B, Peters T, et al. TheDFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1. Hum Mol Genet 2006; 15:751-765.
54. Ahmed Z, Riazuddin S, Khan S, et al. USH1H, a novel locus for type I Usher syndrome, maps to chromosome 15q22-23. Clin Genet 2008; 25 May [Epub ahead of print].
55. Fernandez-Alfonso T, Ryan TA. The efficiency of the synaptic vesicle cycle at central nervous system synapses. Trends Cell Biol 2006; 16:413-420.
56. Adato A, Michel V, Kikkawa Y, et al. Interactions in the network of Usher syndrome type 1 proteins. Hum Mol Genet 2005; 14:347-356.
57. Reiners J, van Wijk E, Marker T, et al. Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. Hum Mol Genet 2005; 14:3933-3943.
58. Maerker T, van Wijk E, Overlack N, et al. A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells. Hum Mol Genet 2008; 17:71-86.
59. Boeda B, EI-Amraoui A, Bahloul A, et al. Myosin Vila, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle. EMBO J 2002; 21:6689-6699.
60. Senften M, Schwander M, Kazmierczak P, et al. Physical and functional interaction between protocadherin 15 and myosin Vlla in mechanosensory hair cells. J Neurosci 2006; 26:2060-2071.
61. Reiners J, Reidel B, EI-Amraoui A, et al. Differential distribution of harmonin isoforms and their possible role in Usher-1 protein complexes in mammalian photoreceptor cells. Invest Ophthalmol Vis Sci 2003; 44:5006-5015.
62. Milewski MI, Lopez A, Jurkowska M, et al. PDZ-binding motifs are unable to ensure correct polarized protein distribution in the absence of additional localization signals. FEBS Lett 2005; 579:483-487.
63. Tonikian R, Zhang Y, Sazinsky SL, et al. A specificity map for the PDZ domain family. PLoS Biol 2008; 6:e239.
64. Adato A, Lefevre G, Delprat B, et al. Usherin, the defective protein in Usher syndrome type NA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. Hum Mol Genet 2005; 14:3921-3932.
65. Siemens J, Kazmierczak P, Reynolds A, et al. The Usher syndrome proteins cadherin 23 and harmonin form a complex by means of PDZ-domain interactions. Proc Natl Acad Sci U S A 2002; 99:14946-14951.
66. Delprat B, Michel V, Goodyear R, et al. Myosin XVa and whirlin, two deafness gene products required for hair bundle growth, are located at the stereocilia tips and interact directly. Hum Mol Genet 2005; 14:401-410.
67. Herrera W, Aleman TS, Cideciyan AV, et al. Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene. Invest Ophthalmol Vis Sci 2008; 49:2651-2660.
68. Hudspeth AJ. How hearing happens. Neuron 1997; 19:947-950.
69. Muller U, Littlewood-Evans A. Mechanisms that regulate mechanosensory hair cell differentiation. Trends Cell Biol 2001; 11:334-342.
70. Vollrath MA, Kwan KY, Corey DP. The micromachinery of mechanotransduction in hair cells. Annu Rev Neurosci 2007; 30:339-365.
71. Lagziel A, Ahmed ZM, Schultz JM, et al. Spatiotemporal pattern and isoforms of cadherin 23 in wild type and waltzer mice during inner ear hair cell development. Dev Biol 2005; 280:295-306.
72. el-Amraoui A, Sahly I, Picaud S, et al. Human Usher 1 B/mouse shaker-1: the retinal phenotype discrepancy explained by the presence/absence of myosin VIIA in the photoreceptor cells. Hum Mol Genet 1996; 5:1171-1178.
73. Hasson T, Walsh J, Cable J, et al. Effects of shaker-1 mutations on myosin-VIIa protein and mRNA expression. Cell Motil Cytoskeleton 1997; 37:127-138.
74. Michel V, Goodyear RJ, Weil D, et al. Cadherin 23 is a component of the transient lateral links in the developing hair bundles of cochlear sensory cells. Dev Biol 2005; 280:281-294.
75. Rzadzinska AK, Derr A, Kachar B, Noben-Trauth K. Sustained cadherin 23 expression in young and adult cochlea of normal and hearing-impaired mice. Hear Res 2005; 208:114-121.
76. Siemens J, Lillo C, Dumont RA, et al. Cadherin 23 is a component of the tip link in hair-cell stereocilia. Nature 2004; 428:950-955.
77. Muller U. Cadherins and mechanotransduction by hair cells. Curr Opin Cell Biol 2008; 20:557-566.
78. Liu X, Bulgakov OV, Darrow KN, et al. Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells. Proc Natl Acad Sci U S A 2007; 104:4413-4418. First report of a mouse model for Usher syndrome manifesting photoreceptor degeneration.
79. McGee J, Goodyear RJ, McMillan DR, et al. The very large G-protein-coupled receptor VLGR1: a component of the ankle link complex required for the normal development of auditory hair bundles. J Neurosci 2006; 26:6543-6553.
80. Michalski N, Michel V, Bahloul A, et al. Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning. J Neurosci 2007; 27:6478-6488.
81. Kussel-Andermann P, El-Amraoui A, Safieddine S, et al. Vezatin, a novel transmembrane protein, bridges myosin VIIA to the cadherin-catenins complex. EMBO J 2000; 19:6020-6029.
82. Reiners J, Nagel-Wolfrum K, Jurgens K, et al. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res 2006; 83:97-119.
83. Gibson F, Walsh J, Mburu P, etal. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 1995; 374:62-64.
84. Johnson KR, Gagnon LH, Webb LS, et al. Mouse models of USH1C and DFNB18: phenotypic and molecular analyses of two new spontaneous mutations of the Ushlc gene. Hum Mol Genet 2003; 12:3075-3086.
85. Di Palma F, Holme RH, Bryda EC, et al. Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1 D. Nat Genet 2001; 27:103-107.
86. Kikkawa Y, Shitara H, Wakana S, et al. Mutations in a new scaffold protein Sans cause deafness in Jackson shaker mice. Hum Mol Genet 2003; 12:453-461.
87. Self T, Mahony M, Fleming J, et al. Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development 1998; 125:557-566.
88. Ahmed ZM, Riazuddin S, Wilcox ER. The molecular genetics of Usher syndrome. Clin Genet 2003; 63:431-444.
89. Wolfrum U, Schmitt A. Rhodopsin transport in the membrane of the connecting cilium of mammalian photoreceptor cells. Cell Motil Cytoskeleton 2000; 46:95-107.
90. Hunter DG, Fishman GA, Mehta RS, Kretzer FL. Abnormal sperm and photoreceptor axonemes in Usher's syndrome. Arch Ophthalmol 1986; 104:385-389.
91. Wolfrum U, Liu X, Schmitt A, et al. Myosin Vlla as a common component of cilia and microvilli. Cell Motil Cytoskeleton 1998; 40:261-271.
92. Barrong SD, Chaitin MH, Fliesler SJ, et al. Ultrastructure of connecting cilia in different forms of retinitis pigmentosa. Arch Ophthalmol 1992; 110:706-710.
93. Adams NA, Awadein A, Toma HS. The retinal ciliopathies. Ophthalmic Genet 2007; 28:113-125.
94. Dryja TP, Adams SM, Grimsby JL, et al. Null RPGRIP1 alleles in patients with Leber congenital amaurosis. Am J Hum Genet 2001; 68:1295-1298.
95. Meindl A, Dry K, Herrmann K, et al. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet 1996; 13:35-42.
96. Blacque OE, Leroux MR. Bardet-Biedl syndrome: an emerging pathomechanism of intracellular transport. Cell Mol Life Sci 2006; 63:2145-2161.
97. Nachury MV, Loktev AV, Zhang Q, et al. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 2007; 129:1201-1213.
98. Reiners J, Marker T, Jurgens K, et al. Photoreceptor expression of the Usher syndrome type 1 protein protocadherin 15 (USH1F) and its interaction with the scaffold protein harmonin (USH1C). Mol Vis 2005; 11:347-355.
99. Reiners J, Wolfrum U. Molecular analysis of the supramolecular usher protein complex in the retina. Harmonin as the key protein of the Usher syndrome. Adv Exp Med Biol 2006; 572:349-353.
100. Williams DS. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Res 2008; 48:433-441. Comprehensive review of animal models in Usher syndrome.
101. Jacobson SG, Cideciyan AV, Aleman TS, et al. Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. Hum Mol Genet 2008; 17:2405-2415.
102. Cremers FP, Kimberling WJ, Kulm M, et al. Development of a genotyping microarray for Usher syndrome. J Med Genet 2007; 44:153-160.
103. Joensuu T, Hamalainen R, Yuan B, et al. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am J Hum Genet 2001; 69:673-684.
104. Brownstein Z, Ben-Yosef T, Dagan O, et al. The R245X mutation of PCDH15 in Ashkenazi Jewish children diagnosed with nonsyndromic hearing loss foreshadows retinitis pigmentosa. Pediatr Res 2004; 55:995-1000.
105. Auslender N, Bandah D, Rizel L, et al. Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews. Genet Test 2008; 12:289-294.
106. Ebermann I, Koenekoop RK, Lopez I, et al. An USH2A founder mutation is the major cause of Usher syndrome type 2 in Canadians of French origin and confirms common roots of Quebecois and Acadians. Eur J Hum Genet 2008 [Epub ahead of print]. doi: 10.1038/ejhg.2008.143.
107. Ebermann I, Lopez I, Bitner-Glindzicz M, et al. Deafblindness in French Canadians from Quebec: a predominant founder mutation in the USH1C gene provides the first genetic link with the Acadian population. Genome Biol 2007; 8:R47.
108. Weston MD, Eudy JD, Fujita S, et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type lla. Am J Hum Genet 2000; 66:1199-1210.
109. Aller E, Najera C, Millan JM, et al. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments. Eur J Hum Genet 2004; 12:407-410.
110. Dreyer B, Brox V, Tranebjaerg L, et al. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. Hum Mutat 2008; 29:451.
111. Dreyer B, Tranebjaerg L, Brox V, et al. A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet 2001; 69:228-234.
112. Dreyer B, Tranebjaerg L, Rosenberg T, et al. Identification of novel USH2A mutations: implications for the structure of USH2A protein. Eur J Hum Genet 2000; 8:500-506.
113. Leroy BP, Aragon-Martin JA, Weston MD, et al. Spectrum of mutations in USH2A in British patients with Usher syndrome type II. Exp Eye Res 2001; 72:503-509.
114. Ouyang XM, Hejtmancik JF, Jacobson SG, et al. Mutational spectrum in Usher syndrome type II. Clin Genet 2004; 65:288-293.
115. Aller E, Jaijo T, Beneyto M, et al. Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II. J Med Genet 2006; 43:e55.
116. Baux D, Larrieu L, Blanchet C, et al. Molecular and in silico analyses of the full-length isoform of usherin identify new pathogenic alleles in Usher type II patients. Hum Mutat 2007; 28:781-789.
117. Baux D, Faugere V, Larrieu L, et al. UMD-USHbases: a comprehensive set of databases to record and analyse pathogenic mutations and unclassified variants in seven Usher syndrome causing genes. Hum Mutat 2008; 29:E76-E87. First publically available comprehensive repository for the growing number of sequence variants relating to Usher syndrome and related nonsyndromic disorders.